Advising women on which pill to take.
作者信息
Guillebaud J
出版信息
BMJ. 1995 Oct 28;311(7013):1111-2. doi: 10.1136/bmj.311.7013.1111.
Abstract
摘要
相似文献
1
Advising women on which pill to take.就服用哪种避孕药向女性提供建议。
BMJ. 1995 Oct 28;311(7013):1111-2. doi: 10.1136/bmj.311.7013.1111.
2
Department of health changes advice on third generation pills.卫生部更改了关于第三代避孕药的建议。
BMJ. 1999 Apr 17;318(7190):1026. doi: 10.1136/bmj.318.7190.1026a.
3
The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.不同剂型口服避孕药对脂质和碳水化合物代谢的影响。
N Engl J Med. 1990 Nov 15;323(20):1375-81. doi: 10.1056/NEJM199011153232003.
4
Influence of the third generation pill controversy on prescriptions for oral contraceptives among first time users: population based study.第三代避孕药争议对首次使用者口服避孕药处方的影响：基于人群的研究。
BMJ. 2003 Feb 1;326(7383):254. doi: 10.1136/bmj.326.7383.254.
5
6
Clinical studies with a new, low-dose oral contraceptive combination, containing 0.150 mg desogestrel and 0.020 mg ethinylestradiol.一项关于新型低剂量口服避孕药组合的临床研究，该组合含有0.150毫克去氧孕烯和0.020毫克炔雌醇。
Acta Obstet Gynecol Scand Suppl. 1987;144:1-44.
7
[The combined effect of an ethinylestradiol/desogestrel contraceptive combination on blood lipids and parameters of liver function and coagulation].
Rev Fr Gynecol Obstet. 1988 Apr;83(4):251-5.
8
Desogestrel, gestodene contraceptives may carry greater thromboembolic risk.去氧孕烯、孕二烯酮避孕药可能具有更高的血栓栓塞风险。
Am J Health Syst Pharm. 1996 Feb 1;53(3):228. doi: 10.1093/ajhp/53.3.228a.
9
Serum resistin levels in women taking combined oral contraceptives containing desogestrel or gestodene.服用含去氧孕烯或孕二烯酮复方口服避孕药的女性血清抵抗素水平。
Contraception. 2004 Jun;69(6):477-80. doi: 10.1016/j.contraception.2004.01.003.
10
Oral contraception and venous thromboembolism. A New Zealand perspective.
Drug Saf. 1997 Feb;16(2):79-87. doi: 10.2165/00002018-199716020-00001.
引用本文的文献
1
Oral contraception and the risk of thromboembolism: what does it mean to clinicians and their patients?口服避孕药与血栓栓塞风险：这对临床医生及其患者意味着什么？
Drug Saf. 2002;25(13):893-902. doi: 10.2165/00002018-200225130-00001.
2
Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.口服避孕药使用者的闭塞性血管疾病。流行病学、病理学及发病机制。
Drugs. 2000 Oct;60(4):721-869. doi: 10.2165/00003495-200060040-00003.
3
A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives.不同复方口服避孕药相关的静脉血栓栓塞性疾病风险比较。
Br J Clin Pharmacol. 2000 Jun;49(6):580-90. doi: 10.1046/j.1365-2125.2000.00198.x.
4
Evidence-based medicine and general practice.循证医学与全科医学
Br J Gen Pract. 1997 Jul;47(420):449-52.
5
Scare over oral contraceptives. Committee's action will undermine further research and development.对口服避孕药的恐慌。委员会的行动将破坏进一步的研发。
BMJ. 1995 Dec 16;311(7020):1639-40. doi: 10.1136/bmj.311.7020.1639c.
6
Scare over oral contraceptives. Studies implicate only gestodene and desogestrel.口服避孕药引发恐慌。研究表明仅孕二烯酮和去氧孕烯有此关联。
BMJ. 1995 Dec 16;311(7020):1639. doi: 10.1136/bmj.311.7020.1639b.
7
Scare over oral contraceptives. Risk is highest during first months of use.口服避孕药引发恐慌。使用的最初几个月风险最高。
BMJ. 1995 Dec 16;311(7020):1639. doi: 10.1136/bmj.311.7020.1639a.
8
Scare over oral contraceptives. If a woman has not had a thrombotic event in years of use she is unlikely to have one now.对口服避孕药的恐慌。如果一名女性在多年使用口服避孕药期间未发生血栓形成事件，那么她现在也不太可能发生。
BMJ. 1995 Dec 16;311(7020):1638-9. doi: 10.1136/bmj.311.7020.1638c.
9
Scare over oral contraceptives. New group will review evidence for effective care in family planning.口服避孕药引发恐慌。新成立的小组将审查计划生育有效护理的证据。
BMJ. 1995 Dec 16;311(7020):1638. doi: 10.1136/bmj.311.7020.1638a.
10
Scare over oral contraceptives. Doctors should take warning seriously.对口服避孕药的恐慌。医生应认真对待这一警告。
BMJ. 1995 Dec 16;311(7020):1638. doi: 10.1136/bmj.311.7020.1638b.
Zotero 插件